Pharmacotherapeutics for
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
• Print ISBN: 9781719648035
eText ISBN:9781719651585
,Question 1
A newly certified family nurse practitioner (FNP) joins a
primary care practice and is preparing to prescribe
independently. Before initiating pharmacotherapy for
patients, the APRN reviews state regulations and
institutional policies. Which action best demonstrates safe,
legally sound prescribing practice?
A. Prescribing medications based solely on national
guidelines regardless of state requirements
B. Verifying state prescriptive authority, DEA registration
requirements, collaborative or independent practice
regulations, and organizational prescribing policies before
prescribing
C. Relying on supervising physicians to ensure all
prescriptions comply with regulations
D. Using pharmaceutical representative recommendations
to determine prescribing authority
Correct Answer: B
Rationale: APRNs are responsible for understanding and
complying with state nurse practice acts, federal
regulations, DEA requirements (when applicable), and
institutional policies before prescribing. These legal
requirements vary by jurisdiction and directly affect
prescribing authority. National guidelines inform clinical
,care but do not supersede legal regulations (A).
Supervising physicians cannot assume the APRN's legal
responsibility (C). Pharmaceutical representatives do not
determine prescribing authority (D).
Question 2
A 58-year-old man with newly diagnosed hypertension
requests medication because his neighbor takes the
"same blood pressure pill." Which response by the APRN
best reflects patient-centered prescribing?
A. Prescribe the same medication because patients with
hypertension often respond similarly.
B. Select therapy after evaluating comorbidities, current
medications, kidney function, patient preferences, and
evidence-based recommendations.
C. Allow the patient to choose the medication he prefers.
D. Delay treatment until symptoms develop.
Correct Answer: B
Rationale: Evidence-based prescribing requires
individualized assessment considering the patient's
medical history, comorbidities, concurrent medications,
organ function, treatment goals, and preferences.
Hypertension management is individualized rather than
based on another patient's therapy. Options A and C
, ignore individualized care, while D delays necessary
treatment.
Question 3
A patient receiving warfarin is prescribed trimethoprim-
sulfamethoxazole by an urgent care clinic. Before
authorizing the prescription refill, the APRN reviews the
patient's medication profile. What is the most appropriate
action?
A. Continue both medications without additional
monitoring.
B. Recognize the clinically significant interaction and
adjust management through alternative therapy or closer
INR monitoring.
C. Stop warfarin immediately.
D. Double the warfarin dose.
Correct Answer: B
Rationale: Safe prescribing requires reviewing potential
drug-drug interactions before initiating therapy.
Trimethoprim-sulfamethoxazole can substantially increase
warfarin's anticoagulant effect, increasing bleeding risk.
Alternative therapy or closer INR monitoring is
appropriate. Abrupt discontinuation of warfarin (C) may
increase thromboembolic risk, while doubling the dose (D)
is dangerous.
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
• Print ISBN: 9781719648035
eText ISBN:9781719651585
,Question 1
A newly certified family nurse practitioner (FNP) joins a
primary care practice and is preparing to prescribe
independently. Before initiating pharmacotherapy for
patients, the APRN reviews state regulations and
institutional policies. Which action best demonstrates safe,
legally sound prescribing practice?
A. Prescribing medications based solely on national
guidelines regardless of state requirements
B. Verifying state prescriptive authority, DEA registration
requirements, collaborative or independent practice
regulations, and organizational prescribing policies before
prescribing
C. Relying on supervising physicians to ensure all
prescriptions comply with regulations
D. Using pharmaceutical representative recommendations
to determine prescribing authority
Correct Answer: B
Rationale: APRNs are responsible for understanding and
complying with state nurse practice acts, federal
regulations, DEA requirements (when applicable), and
institutional policies before prescribing. These legal
requirements vary by jurisdiction and directly affect
prescribing authority. National guidelines inform clinical
,care but do not supersede legal regulations (A).
Supervising physicians cannot assume the APRN's legal
responsibility (C). Pharmaceutical representatives do not
determine prescribing authority (D).
Question 2
A 58-year-old man with newly diagnosed hypertension
requests medication because his neighbor takes the
"same blood pressure pill." Which response by the APRN
best reflects patient-centered prescribing?
A. Prescribe the same medication because patients with
hypertension often respond similarly.
B. Select therapy after evaluating comorbidities, current
medications, kidney function, patient preferences, and
evidence-based recommendations.
C. Allow the patient to choose the medication he prefers.
D. Delay treatment until symptoms develop.
Correct Answer: B
Rationale: Evidence-based prescribing requires
individualized assessment considering the patient's
medical history, comorbidities, concurrent medications,
organ function, treatment goals, and preferences.
Hypertension management is individualized rather than
based on another patient's therapy. Options A and C
, ignore individualized care, while D delays necessary
treatment.
Question 3
A patient receiving warfarin is prescribed trimethoprim-
sulfamethoxazole by an urgent care clinic. Before
authorizing the prescription refill, the APRN reviews the
patient's medication profile. What is the most appropriate
action?
A. Continue both medications without additional
monitoring.
B. Recognize the clinically significant interaction and
adjust management through alternative therapy or closer
INR monitoring.
C. Stop warfarin immediately.
D. Double the warfarin dose.
Correct Answer: B
Rationale: Safe prescribing requires reviewing potential
drug-drug interactions before initiating therapy.
Trimethoprim-sulfamethoxazole can substantially increase
warfarin's anticoagulant effect, increasing bleeding risk.
Alternative therapy or closer INR monitoring is
appropriate. Abrupt discontinuation of warfarin (C) may
increase thromboembolic risk, while doubling the dose (D)
is dangerous.
